download PDF - Newron

Francesco Parenti, a director since 1999, holds a PhD in biological
sciences from the University of Milan and has conducted postdoctoral
research at Yale University. He is currently a partner and
director of Livolsi and Partners, a merchant bank. Previously,
he was the Chief Scientific Officer of Vicuron Pharmaceuticals,
Inc. (formerly, President and Chief Scientific Officer of Biosearch
Italia prior to its merger with Versicor in 2003 which
created Vicuron). A biologist with over 30 years of experience in the pharmaceutical industry,
Dr. Parenti has served as Vice-President of Hoechst Marion Roussel, President (Europe,
Middle East and Africa) for Marion Merrell Dow and General Manager of Dow Lepetit Italy
and has overseen the creation of the Antinfective Research Center at the Merrell Dow
Research Institute. He has also served on the board of directors of several biotechnology
companies. Dr. Parenti is inventor or coinventor of about thirty patents. He is Italian.
Permanent management and consultancy functions for important Swiss and foreign
interest groups: none.
Patrick Langlois, a director since April 2008, was the CFO and
Vice-Chairman of the Management Board of Aventis from
2002 to 2005 and served for 30 years in various senior financial
functions in Rhône-Poulenc and Aventis Group in France and
the USA. Prior to that, he was with Banque Louis-Dreyfus. He
is presently General Partner of PJL Conseils, a consulting firm
in healthcare. He holds a doctorate in economics from University
of Rennes (France). Patrick Langlois is a Board Member of Shire Pharmaceuticals Inc
(UK), Scynexis (USA), Nanobiotix (France) and Exonhit Therapeutics (France). He is French.
Permanent management and consultancy functions for important Swiss and foreign
interest groups: none.
Hanns Moehler, a director since April 2008, is Vice-Director of
the Swiss National Center of Neuroscience Research, of which
he was the first director from 2000 to 2004. He held a professorship
in the Department of Applied Biosciences, ETH Zurich, and
in the Medical Faculty of the University of Zurich, where he
was director of the Institute of Pharmacology from 1988 to 2005.
Prior to his academic positions, Hanns Moehler served as a
Vice-Director in the Research Department of Hoffmann-La Roche, Basel, Switzerland. Prof.
Moehler’s research is devoted to the therapeutic neuroscience of brain disorders. He is a
member of the Swiss Academy of Medical Sciences and the European Academy of Sciences.
Hanns Moehler is German and Swiss.
Permanent management and consultancy functions for important Swiss and foreign
interest groups: none.
22 Newron Annual Report 2011